SFU Library Licensed Material

Access to the content in this collection is restricted to current SFU faculty, students, and staff.

This collection contains various types of content licensed by the SFU Library on behalf of the University. 

Copyright and Terms of use

This work is protected by copyright in Canada unless its copyright has expired. The user is responsible for doing their own assessment. 

You may use this work as permitted by applicable licenses, fair dealing and other exceptions under copyright legislation in your jurisdiction. For guidance on seeking further permissions, contact the source/owner of the material.

Search within Collection

Displaying 286 - 300 of 710

Mergers and Acquisitions in the Medical Device Industry,Datamonitor report

BI00043-008-Thumbnail Image.png
Date: 2011-08-11
Description: The medical device industry has been characterized by aggressive inorganic growth, with large companies seeking to acquire innovative technologies. With large cash reserves available in many device companies, the number of deals is set to increase.

Méthodes pour épreuves textiles Textiles — Dosage du formaldéhyde — Partie 1 : Formaldéhyde libre et hydrolysé (méthode par extraction d'eau) (ISO 14184-1:2011, IDT)

sfulibr_365-Thumbnail Image.png
Date: 2016-01
Description: CAN/CGSB-4.2 No 63.4-2016 ISO 14184-1:2011, IDT Remplace CAN/CGSB-4.2 No 63.4-2007/ISO 14184-1:1998 ICS 59.080.01

Méthodes pour épreuves textiles Textiles — Dosage du formaldéhyde — Partie 2 : Formaldéhyde dégagé (méthode par absorption de vapeur) (ISO 14184-2:2011, IDT)

sfulibr_364-Thumbnail Image.png
Date: 2016-01
Description: CAN/CGSB-4.2 No 63.5-2016 ISO 14184-2:2011, IDT Remplace CAN/CGSB-4.2 No 63.5-2007/ISO 14184-2:1998 ICS 59.080.01

Méthodes pour épreuves textiles Textiles — Essais de solidité des teintures — Partie A01 : Principes généraux pour effectuer les essais (ISO 105-A01:2010, IDT)

sfulibr_368-Thumbnail Image.png
Date: 2016-01
Description: CAN/CGSB-4.2 No 75-2016 ISO 105-A01:2010, IDT Remplace CAN/CGSB-4.2 No 75-2004/ISO 105-A01:1994 ICS 59.080.01

Mobilities of return

sfulibr_1386-Thumbnail Image.png
Date: 2017

Modern Labour Activism

sfulibr_1327-Thumbnail Image.png
Date: 2017-09-04

Money and Employment: The Collected Writings of Paul Davidson, Volume 1.

sfulibr_1475-Thumbnail Image.png

Nanotechnology in Healthcare,Datamonitor report

BI00020-026-Thumbnail Image.png
Date: 2010-01-04
Name(s): Merchant, Mahi
Description: Nanotechnology is playing an increasingly important role in combating disease, especially in treating cancer. Advanced technological developments in coatings and implants using nanotechnology are expected to increase the scope of its application.

Nanotechnology,Datamonitor report

BI00020-010-Thumbnail Image.png
Date: 2008-01-08
Name(s): Barton, Cheryl L.
Description: Advances in nanotechnologies will drive the value of the global nanotechnology market to a trillion dollars by 2015, but many companies are remaining cautious, preferring to monitor developments in academia pior to makeing substantial investments.

Natural Nutraceutical Patent Strategies,Datamonitor report

BI00047-006-Thumbnail Image.png
Date: 2011-09-15
Name(s): Buggle, Irene
Description: With regulators demanding well-designed clinical trials and substantial supporting evidence, the cost of developing nutraceuticals is increasing. Protecting the intellectual property surrounding these products is a critical issue.

Natural Nutraceutical Patent Strategy Case Studies,Datamonitor report

BI00047-008-Thumbnail Image.png
Date: 2011-09-15
Name(s): Buggle, Irene
Description: With increased investment and development time required to produce a nutraceutical, the accompanying intellectual property becomes critical. This report looks at the strategies required to protect IP and details key innovative company case studies.

Navigating Health Claim Regulation in Food and Drinks,Datamonitor report

BI00014-018-Thumbnail Image.png
Date: 2009-05-27
Name(s): Berezai, Piers
Description: The impact of the new regulation on nutrition and health claims made on foods (and drinks) is only just starting to be felt. Currently, media and industry attention is highly focused on the claims approval process and the problems this is causing.

Negotiating the Emerging Biosimilars Landscape,Datamonitor report

BI00027-018-Thumbnail Image.png
Date: 2009-02-02
Name(s): Taylor, Paul
Description: As regulatory obstacles to biosimilars development have become increasingly resolved, a growing number of opportunities have been created for generics companies in the biopharmaceutical market.

New Approaches to Gaining Market Access for Pharmaceuticals,Datamonitor report

BI00027-051-Thumbnail Image.png
Date: 2010-09-30
Name(s): Marchant, Jeanette
Description: Market access is becoming more challenging for new pharmaceuticals, especially expensive treatments that drive up drug spending. More emphasis is being placed on value for money, with economic evaluation becoming part of the equation.

New Developments in Retail-Ready Packaging,Datamonitor report

BI00051-003-Thumbnail Image.png
Date: 2011-12-02
Name(s): Barnett, Ian
Description: Retail-ready packaging offers manufacturers and retailers significant savings in the face of rising costs. New innovations mean that RRP can be utilized more than ever before to optimize operational efficiencies and enhance brand presence in store.